Καινοτομία

An EU-funded project has made important advances in our understanding of how catalytic molecules can treat Alzheimer’s – and other – chronic diseases.

Alzheimer's disease is the most common form of dementia, with symptoms that include gradually worsening memory loss and confusion. At present there is no cure. Scientists are nonetheless confident that as we learn more about the natural processes of the body, quicker diagnoses and more effective therapies can be developed.